Global Sciatica Treatment Market is expected to foresee significant growth. North America to lead the growth!

Global Sciatica treatment market is expected to register a CAGR of approx. 8% over the period of 2022-2028. Sciatica is a lower back pain that originates in the sciatic nerve and travels down one or both legs. The sciatic nerve is the largest in the human body. The sciatic nerve begins at the lumbar spinal cord nerve origins in the lower back and travels through the buttocks to direct nerve terminals below the lower limb. The disease develops when a bone spur on the spine compresses a nerve. This causes stiffness and pain in the surrounding area. The most common symptom of sciatica is mild to severe pain that runs from the lower back to the buttocks. Furthermore, the patient may experience a burning sensation, which can sometimes feel like a jolt. The global sciatica treatment market is rising due to the increasing prevalence of backbone and sciatica nerve-related problems such as slipped disc, lumber degenerative disc disease, spinal stenosis, spondylolisthesis, etc. For instance, according to IQWiG (Institute for Quality and Efficiency in Health Care), in 2020, It is estimated that 1 to 5% of all people will have back pain caused by a slipped disc at some point in their lives. Slipped discs are more common in people over the age of 30 and are about twice as common in men as they are in women. Owing to these glaring statistics the demand for sciatica treatment is anticipated to grow in the forthcoming year cases of people suffering from a slipped disc are increasing significantly due to changing lifestyles. Moreover, the increasing underlying demand for the design and development of novel therapeutics for treatment is fueling the demand for the sciatica treatment market. Furthermore, the increasing geriatric population in the past few years and extra pressure on the spine due to other health conditions is expected to drive the market for sciatica treatment market in the coming years.

For a detailed analysis of the Global Sciatica Treatment Market browse through – https://univdatos.com/report/sciatica-treatment-market/

Based on the type, the sciatica treatment market is segmented into acute sciatica, chronic sciatica, and others. The acute sciatica segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. Acute sciatica occurs for a shorter duration of time due to compression in the sciatica nerve compression. It generally occurs in the young generation or working population.

Based on therapy, the market is fragmented into physical therapy, chiropractic therapy, stimulation devices, and others. The physical therapy segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. It incorporates a combination of strengthening, stretching, and aerobic conditioning and is a central component of almost any sciatica treatment plan.

For a better understanding of the market adoption of sciatica treatment market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the sciatica treatment industry owing to the awareness among the people about the sciatica disease and the availability of advanced medications.

Some of the major players operating in the market include Endo Pharmaceuticals Inc, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services Inc, Omega Laser Systems Ltd., Pfizer Inc, Sanofi, Aurobindo Pharmaceutical, Glenmark Pharmaceutical Ltd.
Request for Sample of the report browse through – https://univdatos.com/pre-book-report-php/?product_id=29701

Global Sciatica Treatment Market Segmentation

Market Insight, by Type

• Acute Sciatica
• Chronic Sciatica
• Others

Market Insight, by Therapy

• Physical Therapy
• Chiropractic Therapy
• Stimulation devices
• Others

Market Insight, by Treatment

• Medication
• Surgery

Market Insight, by Drug

• Anesthetics
• Pain killers
• Muscle relaxants
• Antidepressants
• Steroids
• Others

Market Insight, by End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Market Insight, by Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Australia
  • Japan
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• Endo Pharmaceuticals Inc
• AstraZeneca
• Novartis AG
• Teva Pharmaceutical Industries Ltd
• Johnson & Johnson Services Inc
• Omega Laser Systems Ltd.
• Pfizer Inc
• Sanofi
• Aurobindo Pharmaceutical
• Glenmark Pharmaceutical Ltd.